GI
ARCT icon

GAMMA Investing’s Arcturus Therapeutics ARCT Stock Holding History

GAMMA Investing’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.2K Sell
1,619
-131
-7% -$1.37K ﹤0.01% 2886
2026
Q2 		$11.8K Buy
1,750
+244
+16% +$1.92K ﹤0.01% 3127
2026
Q1 		$11.6K Buy
1,506
+1,044
+226% +$7.62K ﹤0.01% 2995
2025
Q4 		$2.83K Sell
462
-162
-26% -$1.75K ﹤0.01% 3500
2025
Q3 		$11.5K Buy
624
+43
+7% +$691 ﹤0.01% 2817
2025
Q2 		$7.56K Buy
581
+87
+18% +$1.03K ﹤0.01% 2950
2025
Q1 		$5.23K Buy
494
+348
+238% +$5.52K ﹤0.01% 3070
2024
Q4 		$2.48K Buy
146
+29
+25% +$546 ﹤0.01% 3157
2024
Q3 		$2.72K Sell
117
-61
-34% -$1.3K ﹤0.01% 2968
2024
Q2 		$4.33K Buy
178
+124
+230% +$3.76K ﹤0.01% 2636
2024
Q1 		$1.82K Buy
54
+5
+10% +$177 ﹤0.01% 2774
2023
Q4 		$1.62K Buy
+49
New +$1.17K ﹤0.01% 2648

Other funds holding ARCT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return

GAMMA Investing's ARCT Position: Q3 2026 in Review

GAMMA Investing reduced its Arcturus Therapeutics (ARCT) stake by 7.5% in Q3 2026, selling an estimated $1.37K and leaving 1,619 shares worth $22.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2886.

GAMMA Investing first reported a position in ARCT in Q4 2023 and has held it in 12 quarters since. 10 funds tracked by Wall St. Rank hold ARCT as of Q3 2026.

  • GAMMA Investing held 1,619 shares of Arcturus Therapeutics worth $22.2K as of Q3 2026.
  • GAMMA Investing sold 131 Arcturus Therapeutics shares in Q3 2026, an estimated $1.37K.
  • Arcturus Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2886 holding.
  • GAMMA Investing first reported a position in Arcturus Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • 10 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.